Quantcast
Channel: Life Science Investing News» Amgen
Viewing all articles
Browse latest Browse all 7

Insulet Announces Commercial Agreement With Amgen

$
0
0

Insulet Corporation (NASDAQ:PODD), which has a tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced an agreement with Amgen Inc. (NASDAQ:AMGN) for a 5-year commercial agreement to supply Amgen with a delivery device designed around the delivery needs of biotechnology medicines.

Continue reading...

Viewing all articles
Browse latest Browse all 7

Latest Images

Trending Articles





Latest Images